Free Trial

New York State Teachers Retirement System Acquires 3,899 Shares of Cigna Group $CI

Cigna Group logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • New York State Teachers Retirement System increased its stake in Cigna by 1.9% in Q4, acquiring an additional 3,899 shares to own 213,343 shares (about 0.08%) valued at roughly $58.72 million.
  • Cigna beat Q1 estimates (EPS $7.79 vs. $7.60; revenue $68.52B vs. ~$66.29B) and raised its FY‑2026 adjusted EPS outlook to at least $30.35, driven in part by strong Evernorth performance.
  • Insider activity & dividend: Insiders Nicole S. Jones and Everett Neville sold 2,307 and 1,719 shares respectively at about $288.91 on March 2, and the company declared a $1.56 quarterly dividend (annualized $6.24, ~2.1% yield).
  • MarketBeat previews top five stocks to own in June.

New York State Teachers Retirement System increased its holdings in Cigna Group (NYSE:CI - Free Report) by 1.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 213,343 shares of the health services provider's stock after acquiring an additional 3,899 shares during the quarter. New York State Teachers Retirement System owned about 0.08% of Cigna Group worth $58,718,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. Beacon Financial Strategies CORP purchased a new position in shares of Cigna Group during the fourth quarter valued at approximately $28,000. Collier Financial purchased a new position in Cigna Group during the third quarter valued at $34,000. Lodestone Wealth Management LLC purchased a new stake in shares of Cigna Group in the fourth quarter worth $32,000. Activest Wealth Management increased its holdings in shares of Cigna Group by 1,050.0% during the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider's stock valued at $38,000 after acquiring an additional 126 shares in the last quarter. Finally, Founders Capital Management boosted its stake in Cigna Group by 53.0% in the 3rd quarter. Founders Capital Management now owns 153 shares of the health services provider's stock worth $44,000 after purchasing an additional 53 shares in the last quarter. Institutional investors own 86.99% of the company's stock.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

  • Positive Sentiment: Cigna beat Q1 earnings expectations and raised its FY‑2026 adjusted EPS outlook to at least $30.35, signaling stronger profitability than analysts expected. Cigna Q1 Earnings Beat Estimates
  • Positive Sentiment: Evernorth (Cigna’s health services/pharmacy-benefit unit) showed double‑digit revenue growth and drove margin/operational strength in the quarter, helping offset pharmacy cost pressures. Cigna Revenue Rises on Evernorth Growth
  • Positive Sentiment: Company press release and Reuters coverage confirm revenue beat (~$68.5B) and a slight upward tweak to the annual adjusted profit forecast — fundamentals support near‑term earnings visibility. Cigna Reports Strong Q1 & Raises Outlook
  • Neutral Sentiment: Market commentary and bullish research notes (Substack summaries, analyst price targets) reiterate long‑term upside based on valuation and diversified businesses, but these are opinions rather than new catalysts. Is CI a Good Stock to Buy?
  • Negative Sentiment: Cigna announced it will exit the Affordable Care Act individual market in 2027, affecting roughly 369,000 members — a near‑term subscriber loss and political/regulatory risk that likely pressured the stock. Cigna to Exit ACA Market
  • Negative Sentiment: Quiver/filings show large institutional reductions from some major managers in recent quarters, which could amplify selling pressure even after the beat. Quiver Quantitative CI Earnings & Holdings
  • Negative Sentiment: Analysts and reports note rising pharmacy costs; while Evernorth grew revenue, higher PBM/pharmacy expense remains a margin risk to monitor. PBM/Pharmacy Cost Commentary

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider owned 5,670 shares in the company, valued at $1,638,119.70. This represents a 23.26% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company's stock.

Cigna Group Stock Performance

Shares of CI opened at $290.58 on Friday. The firm has a market capitalization of $76.58 billion, a P/E ratio of 13.10, a PEG ratio of 1.01 and a beta of 0.26. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.74. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The business has a fifty day moving average of $274.34 and a 200 day moving average of $276.94.

Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating analysts' consensus estimates of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.Cigna Group's revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 30.32 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Thursday, June 4th. Cigna Group's dividend payout ratio is 28.13%.

Wall Street Analyst Weigh In

CI has been the subject of a number of analyst reports. Jefferies Financial Group reduced their price objective on shares of Cigna Group from $333.00 to $330.00 and set a "buy" rating for the company in a research note on Monday, April 20th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Cigna Group from $301.00 to $304.00 and gave the stock a "buy" rating in a report on Tuesday, February 10th. TD Cowen lifted their target price on Cigna Group from $333.00 to $338.00 and gave the stock a "buy" rating in a report on Monday, February 9th. Sanford C. Bernstein raised Cigna Group from a "market perform" rating to an "outperform" rating and upped their price target for the company from $307.00 to $358.00 in a report on Thursday, March 12th. Finally, Royal Bank Of Canada decreased their target price on Cigna Group from $344.00 to $333.00 and set an "outperform" rating for the company in a research report on Friday, February 6th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $332.47.

Read Our Latest Analysis on CI

About Cigna Group

(Free Report)

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines